₹ 256000 / 2000 Shares Shares
Minimum Investment
₹120-128 per equity share
07 Nov 2025
11 Nov 2025
1000
₹ 256000
₹120-128
14 Nov 2025
21,50,000 shares(aggregating up to ₹27.52 crore)
₹10 Per Equity Share
2000 Shares
2000 Shares
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
2020
Dharmesh Dasharathbhai Patel
Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Yes, KSquare provides responsive support and scheduling flexibility for NRIs in all global time zones.
Yes, KSquare allows SIP setup, automating monthly investments to help build disciplined saving habits.
While credit score matters, lenders also consider the value and type of mutual funds pledged. KSquare helps assess your eligibility beforehand.
Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.
Yes, KSquare helps NRIs complete the KYC process digitally, making onboarding quick and hassle-free.
The loan value is based on the mutual fund's NAV and the lender’s margin requirements. KSquare shows your eligible amount during application.
Mutual funds pool money from many investors to invest in a diversified portfolio of stocks, bonds, or other assets managed by professionals.
No penalties are charged by mutual funds for missing SIPs, but your bank may charge ECS failure fees if funds are insufficient.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.